PSTV•benzinga•
Plus Therapeutics And SpectronRx Announced The Signing Of A Manufacturing Services Agreement For The Production Of Rhenium (186Re) Obisbemeda, An Innovative Radiotherapy For CNS Cancers, Including Leptomeningeal Metastases And Recurrent Glioblastoma
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 6, 2024 by benzinga